Fairmount Funds Management LLC
- SEC CIK
- 0001802528
- Latest filing
- Aug 14, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 14, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 17
- 0 vs. Q2 2025
- Portfolio value
- $1.11B
- +$339.5M (+44.0%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DNTHDianthus Therapeutics, Inc. | COM | 3,307,191 | $130.1M | 11.7% | +600,000+22.2% | Added | History |
| COGTCogent Biosciences, Inc. | COM | 9,003,418 | $129.3M | 11.6% | +2,777,777+44.6% | Added | History |
| AXSMAxsome Therapeutics, Inc. | COM | 815,176 | $99.0M | 8.9% | 00.0% | Unchanged | History |
| APGEApogee Therapeutics, Inc. | COM | 2,048,647 | $81.4M | 7.3% | 00.0% | Unchanged | History |
| ELVNEnliven Therapeutics, Inc. | COM | 3,711,444 | $76.0M | 6.8% | 00.0% | Unchanged | History |
| VRDNViridian Therapeutics, Inc. | COM | 3,459,913 | $74.7M | 6.7% | 00.0% | Unchanged | History |
| ORKAOruka Therapeutics, Inc. | COM | 3,705,262 | $71.3M | 6.4% | +333,340+9.9% | Added | History |
| KNSAKiniksa Pharmaceuticals International, plc | ORD SHS CL A | 1,772,839 | $68.8M | 6.2% | 00.0% | Unchanged | History |
| SRRKScholar Rock Holding Corp | COM | 1,824,031 | $67.9M | 6.1% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 4,018,101 | $67.3M | 6.1% | 00.0% | Unchanged | History |
| NUVLNuvalent, Inc. | COM | 727,563 | $62.9M | 5.7% | 00.0% | Unchanged | History |
| ABVXAbivax S.A. | SPONSORED ADS | 713,434 | $60.6M | 5.4% | +713,434 | New | History |
| ZBIOZenas BioPharma, Inc. | COM | 1,892,806 | $42.0M | 3.8% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM NEW | 3,220,368 | $27.8M | 2.5% | 00.0% | Unchanged | History |
| ATXSAstria Therapeutics, Inc. | COM | 3,554,129 | $25.9M | 2.3% | 00.0% | Unchanged | History |
| CBIOCrescent Biopharma, Inc. | COM | 1,387,866 | $16.5M | 1.5% | 00.0% | Unchanged | History |
| IKTInhibikase Therapeutics, Inc. | COM NEW | 6,125,000 | $9.92M | 0.9% | 00.0% | Unchanged | History |
Sold out since Q2 2025 (1)
Positions held at the end of Q2 2025 that are gone from this filing.